Author(s):
K. Bhavyasri, M. Manisha
Email(s):
bhavya.khagga@gmail.com
DOI:
10.5958/0974-360X.2020.00227.9 
Address:
Dr. K. Bhavyasri1*, M. Manisha2
1Head of Department of Pharmaceutical Analysis, RBVRR Women’s College Of Pharmacy, Barkatpura, Hyderabad, Telangana-500027, India.
2Department of Pharmaceutical Analysis, RBVRR Women’s College Of Pharmacy, Barkatpura, Hyderabad, Telangana-500027, India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2020
ABSTRACT:
A simple, sensitive and reproducible Spectrophotometric method is developed for estimation of Tenofovir Alafenamide Fumarate (TAF) in bulk and its tablet dosage form. Forced degradation studies are also conducted on standard TAF and % degradation of drug under various stress conditions is reported. Different concentrations of TAF are prepared using distilled water: acetonitrile as diluent. The absorption maximum of TAF is found to be at 261nm. Linearity was established in the range of 6.25-37.5 µg/ml with regression coefficient of 0.999. The drug was subjected to acid and alkali hydrolysis, oxidation degradation, thermal and photo degradation conditions.
Cite this article:
K. Bhavyasri, M. Manisha. UV-Spectrophotometric estimation and forced Degradation studies of Tenofovir Alafenamide fumarate (TAF) in its Bulk and Tablet Dosage Form. Research J. Pharm. and Tech 2020; 13(3):1231-1235. doi: 10.5958/0974-360X.2020.00227.9
Cite(Electronic):
K. Bhavyasri, M. Manisha. UV-Spectrophotometric estimation and forced Degradation studies of Tenofovir Alafenamide fumarate (TAF) in its Bulk and Tablet Dosage Form. Research J. Pharm. and Tech 2020; 13(3):1231-1235. doi: 10.5958/0974-360X.2020.00227.9 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-3-32
REFERENCES:
1. Sk.
Mastanamma et. al., Development and Validation of RP-HPLC Method for the
Simultaneous Estimation of Lamivudine, Tenofovir Alafenamide and Dolutegravir
Bulk and their Combined Dosage Form. Pharma methods. 2018; 9(2): 49-55.
2. N. MD. Akram et. al., A New Validated
RP-HPLC Method for the Determination of Emtricitabine and Tenofovir AF in its
Bulk and Pharmaceutical Dosage Forms. Journal of Chemical and Pharmaceutical
Sciences. 2017; 10(4): 54-59.
3. Benzil Dudekula et. al., Development
and Validation of RP-HPLC Method for Simultaneous Estimation of Emtricitabine
and Tenofovir Alafenamide in Bulk and Tablet Dosage Form. European Journal of
Biomedical and Pharmaceutical Sciences. 2017; 10(4): 663-668.
4. Sk.
Mastanamma et. al., Development and Validation of Stability Indicating
RP-HPLC Method for the Simultaneous Estimation of Emtricitabine, Tenofovir
Alafenamide Bulk and their Combined Dosage Form. Journal of Current
Pharma Research. 2017; 9(9): 70-80.
5. Bhushan
P. Badgujar et. al., Development and Validation of RP-HPLC Method for
the Simultaneous Estimation of Tenofovir Alafenamide and Emtricitabine in Bulk
and Tablet Dosage Form. International
Journal of ChemTech Research. 2017; 10(5): 731-739.
6. Ashwini
Shelke et. al., Application of UV Spectrophotometric Methods for
Simultaneous Estimation of Emtricitabine and Tenofovir Alafenamide Fumarate in
Bulk. Asian Journal of Pharmacy and Technology. 2018; 8(2): 103-107.
7. M.P.
Shinde et. al., development of a
UV-spectrometric method for study of degradation profile of Tenofovir
Alafenamide. International Journal of Pharmaceutical Chemistry and Analysis.
2018; 5(3): 144-146.
8. Pankaj Kumar et. al., Spectroscopic Estimation of
Tenofovir Alafenamide, an antiretroviral drug. Research Journal of Pharmacy and
Technology. 2016; 9(5): 538-540.
9. Asif
Husain et. al., Forced Degradation Studies. Journal of Analytical &
Pharmaceutical Research, 2016; 3(6): 00073.
10. High
performance liquid chromatography, quantitative analysis of pharmaceutical formulations,
volume-1, P. D. Sethi.
11. Clarke’s
analysis of drugs and poisons, third edition, edited by Anthony C Moffat, M.
David Osselton, and Brian Widdap.
12. Instrumental
methods of chemical analysis, indian edition, Galen W. Ewing.
13. Instrumental
Analysis, Indian Edition, Skoog, Holler, Crouch.
14. Pharmacokinetics
and pharmaco dynamics by CVS Subramanian.
15. Spectroscopy,
Indian edition, Pavia, Lampman, Kriz, Vyvyan.
16. Tenofovir Alafenamide – DrugBank
17. Tenofovir Alafenamide C21H29N6O5P –
PubChem
18. ICH
Q1A, Q1B, Q2 (Stability studies and analytical method validation).